AMPK suppresses Th2 cell responses by repressing mTORC2
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Allergic inflammation is a T helper 2 (Th2) cell-driven pathophysiological phenomenon, but the mechanism by which the metabolic cascade affects Th2 cell differentiation remains unclear. In this study, we investigated the roles of AMP-activated protein kinase (AMPK) and intracellular energy sensors in Th2 cell differentiation and the pathogenesis of allergic inflammation. Accordingly, T-cell-specific AMPK or Sirtuin 1 (Sirt1)-knockout mice were subjected to allergic inflammation, and their Th2 cell responses were investigated. The results demonstrated that inducing allergic inflammation in AMPK- and Sirt1-knockout mice increased Th2 cell responses and exacerbated allergic phenotypes. Furthermore, treatment with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an activator of AMPK, ameliorated allergic inflammation in mice. Mechanistically, our findings revealed that AMPK repressed mechanistic target of rapamycin complex 2 (mTORC2), which downregulated the expression of suppressor of cytokine signaling 5 (SOCS5) in CD4+ T cells. In addition, the loss of AMPK signaling reduced SOCS5 expression and increased interleukin-4-STAT6–GATA3 axis-mediated Th2 cell differentiation. Finally, the T-cell-specific deletion of Rictor, a member of mTORC2, in Sirt1T-KO mice led to the reversal of allergic exacerbation to the level in control mice. Overall, our findings suggest that AMPK in CD4+ T cells inhibits the differentiation of Th2 cells by repressing mTORC2 and thus serves as a potential target for Th2 cell-associated diseases.
Abstract
Allergic inflammation is a T helper 2 (Th2) cell-driven pathophysiological phenomenon, but the mechanism by which the metabolic cascade affects Th2 cell differentiation remains unclear. In this study, we investigated the roles of AMP-activated protein kinase (AMPK) and intracellular energy sensors in Th2 cell differentiation and the pathogenesis of allergic inflammation. Accordingly, T-cell-specific AMPK or Sirtuin 1 (Sirt1)-knockout mice were subjected to allergic inflammation, and their Th2 cell responses were investigated. The results demonstrated that inducing allergic inflammation in AMPK- and Sirt1-knockout mice increased Th2 cell responses and exacerbated allergic phenotypes. Furthermore, treatment with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an activator of AMPK, ameliorated allergic inflammation in mice. Mechanistically, our findings revealed that AMPK repressed mechanistic target of rapamycin complex 2 (mTORC2), which downregulated the expression of suppressor of cytokine signaling 5 (SOCS5) in CD4+ T cells. In addition, the loss of AMPK signaling reduced SOCS5 expression and increased interleukin-4-STAT6–GATA3 axis-mediated Th2 cell differentiation. Finally, the T-cell-specific deletion of Rictor, a member of mTORC2, in Sirt1T-KO mice led to the reversal of allergic exacerbation to the level in control mice. Overall, our findings suggest that AMPK in CD4+ T cells inhibits the differentiation of Th2 cells by repressing mTORC2 and thus serves as a potential target for Th2 cell-associated diseases.
참고문헌 (63)
- Pennock, N. D., "T cell responses: naive to memory and everything in between", Adv. Physiol. Educ, 37, pp.273~283 (2013)
- Zheng, W. -p., "The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells", Cell, 89, pp.587~596 (1997)
- Maier, E., "STAT6-dependent and-independent mechanisms in T h2 polarization", Eur. J. Immunol, 42, pp.2827~2833 (2012)
- McCormick, S. M., "Suppressor of cytokine signaling(SOCS)1 regulates interleukin-4(IL-4)-activated insulin receptor substrate(IRS)-2 tyrosine phosphorylation in monocytes and macrophages via the proteasome", J. Biol. Chem, 291, pp.20574~20587 (2016)
- Seki, Y. -i., "Expression of the suppressor of cytokine signaling-5(SOCS5)negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation", Proc. Natl Acad. Sci. USA, 99, pp.13003~13008 (2002)
- Delgoffe, G. M., "The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2", Nat. Immunol, 12, pp.295~303 (2011)
- Garcia, D., "AMPK : mechanisms of cellular energy sensing and restoration of metabolic balance", Mol. Cell, 66, pp.789~800 (2017)
- Blagih, J., "The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo", Immunity, 42, pp.41~54 (2015)
- Park, M. -J., "Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin", signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs, 2016, pp.173, 115~130
- Ramiscal, R. R., "Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation", Elife, 4, pp.e08698~ (2015)
- MacIver, N. J., "The liver kinase B1 is a central regulator of T cell development, activation, and metabolism", J. Immunol, 187, pp.4187~4198 (2011)
- Blagih, J., "LKB 1 and AMPK : central regulators of lymphocyte metabolism and function", Immunol. Rev, 249, pp.59~71 (2012)
- Timilshina, M., "Activation of mevalonate pathway via LKB1 is essential for stability of Treg cells", Cell Rep, 2, pp.2948~2961.e2947 (2019)
- Pokhrel, R. H., "AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR", p38 signaling pathway, 2021, pp.20, 133~
- Tindemans, I., "GATA-3 function in innate and adaptive immunity", Immunity, 41, pp.191~206 (2014)
- Herzig, S., "AMPK : guardian of metabolism and mitochondrial homeostasis", Nat. Rev. Mol. Cell Biol, 19, pp.121~ (2018)
- Mayer, K. A., "The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells", FASEB J, 35, pp.e21217~ (2021)
- Waickman, A. T., "mTOR, metabolism, and the regulation of T-cell differentiation and function", Immunol. Rev, 249, pp.43~58 (2012)
- Soliman, G. A., "The expanding role of the mammalian target of rapamycin complex 2(mTORC2)in cellular metabolism", Arch. Med, 7, pp.1~8 (2015)
- Han, D., "LKB1", AMPK, Asian Pac. J. Cancer Prev, pp.2013, 14[DOI]
- Na, H., "Concomitant suppression of TH2 and TH17 cell responses in allergic asthma by targeting retinoic acid receptor-related orphan receptor γt", J. Allergy Clin. Immunol, 141, pp.2061~2073.e2065 (2018)[DOI]
- Morokata, T., "C57BL", 6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB, T helper 2 responses, pp.Immunology, 1999[DOI]
- Woods, A., "LKB1 is the upstream kinase in the AMP-activated protein kinase cascade", Curr. Biol, 13, pp.2004~2008 (2003)
- Pandit, M., "LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1", J. Mol. Med, 99, pp.1139~1150 (2021)
- Ruderman, N. B., "AMPK and SIRT1: a long-standing partnership?", Am. J. Physiol. Endocrinol. Metab, 298, pp.E751~E760 (2010)
- Limagne, E., "Sirtuin-1 activation controls tumor growth by impeding Th17differentiation via STAT3 deacetylation", Cell Rep, 19, pp.746~759 (2017)
- Wang, Y., "Histone deacetylase SIRT1 negatively regulates the differentiation of interleukin-9-producing CD4+ T cells", Immunity, 44, pp.1337~1349 (2016)
- Lamming, D. W., "Depletion of Rictor, an essential protein component of m TORC 2, decreases male lifespan", Aging Cell, 13, pp.911~917 (2014)
- Cox, A., "A new standard genetic map for the laboratory mouse", Genetics, 182, pp.1335~1344 (2009)
- Galli, S. J., "The development of allergic inflammation", Nature, 454, pp.445~454 (2008)
- Ma, E. H., "The role of AMPK in T cell metabolism and function", Curr. Opin. Immunol, 46, pp.45~52 (2017)
- Marchingo, J. M., "Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation", Elife, 9, pp.e53725~ (2020)
- Roy, S., "Metabolic checkpoints in differentiation of helper T cells in tissue inflammation", Front. Immunol, 9, pp.3036~ (2019)
- Michalek, R. D., "Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets", J. Immunol, 186, pp.3299~3303 (2011)
- Nurieva, R. I., "Transcriptional regulation of th2 differentiation by inducible costimulator", Immunity, 18, pp.801~811 (2003)
- Iwaoka, R., "Glucose regulates MafA transcription factor abundance and insulin gene expression by inhibiting AMP-activated protein kinase in pancreatic β-cells", J. Biol. Chem, 293, pp.3524~3534 (2018)
- Lin, S. -C., "AMPK : sensing glucose as well as cellular energy status", Cell Metab, 27, pp.299~313 (2018)
- Kazyken, D., "AMPK directly activates mTORC2 to promote cell survival during acute energetic stress", Sci. Signal, 12, pp.eaav3249~ (2019)
- Gao, M., "AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin", Oncotarget, 7, pp.16349~ (2016)
- Wang, Y., "Metformin induces autophagy and G0", G1 phase cell cycle arrest in myeloma by targeting the AMPK, J. Exp. Clin. Cancer Res, pp.2018, 37[DOI]
- Kang, J. I., "Anti-tumor activity of yuanhuacine by regulating AMPK", mTOR signaling pathway and actin cytoskeleton organization in non-small cell lung cancer cells, 2015, pp.10, e0144368~
- Wu, T. D., "Metformin use and respiratory outcomes in asthma-COPD overlap", Respir. Res, 22, pp.1~8 (2021)
- Wen, L., "Association of metformin use with asthma exacerbation in patients with concurrent asthma and diabetes : a systematic review and meta-analysis of observational studies", Can. Respir. J, 2020, pp.9705604~ (2020)
- Calixto, M. C., "Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice", PloS ONE, 8, pp.e76786~ (2013)
- Spencer, L. A., "Eosinophils and Th2 immunity : contemporary insights", Immunol. Cell Biol, 88, pp.250~256 (2010)
- Fattahi, F., "HuR-targeted inhibition impairs Th2 proinflammatory responses in asthmatic CD4+ T cells", J. Immunol, 208, pp.38~48 (2022)
- Howell, J. J., "Metformin inhibits hepatic mTORC1 signaling via dosedependent mechanisms involving AMPK and the TSC complex", Cell Metab, 25, pp.463~471 (2017)
- Sarbassov, D. D., "Phosphorylation and regulation of Akt", PKB by the rictor-mTOR complex, 2005, pp.307, 1098~1101
- Vadlakonda, L., "The paradox of Akt-mTOR interactions", Front. Oncol, 3, pp.165~ (2013)
- Chen, Y., "mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2", PIK3CA-hyperactive breast cancer, 2016, pp.7, 25224~
- Um, S. H., "Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity", Nature, 431, pp.200~205 (2004)
- Heikamp, E. B., "The AGC kinase SGK1 regulates TH 1 and TH 2 differentiation downstream of the mTORC2 complex", Nat. Immunol, 15, pp.457~464 (2014)
- MacIver, N. J., "Metabolic regulation of T lymphocytes", Annu. Rev. Immunol, 31, pp.259~283 (2013)
- Colley, T., "Defective sirtuin-1 increases IL-4 expression through acetylation of GATA-3 in patients with severe asthma", J. Allergy Clin. Immunol, 137, pp.1595~1597 (2016)[DOI]
- Wang, R. -H., "Hepatic Sirt1 deficiency in mice impairs mTorc2", Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance, 2011, pp.121, 4477~4490
- Hou, X., "SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase", J. Biol. Chem, 283, pp.20015~20026 (2008)
- Lan, F., "SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 possible role in AMP-activated protein kinase activation", J. Biol. Chem, 283, pp.27628~27635 (2008)
- Suchankova, G., "Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells", Biochem. Biophys. Res. Commun, 378, pp.836~841 (2009)
- Price, N. L., "SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function", Cell Metab, 15, pp.675~690 (2012)
- Lee, K., "Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways", Immunity, 32, pp.743~753 (2010)
- Kwon, M. -J., "Protein kinase C-θ promotes Th17 differentiation via upregulation of Stat3", J. Immunol, 188, pp.5887~5897 (2012)
- Hebenstreit, D., "SOCS-1and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3", CCL26 gene expression in HEK293 cells, 2005, pp.42, 295~303
- Saleiro, D., "Intersection of mTOR and STAT signaling in immunity", Trends Immunol, 36, pp.21~29 (2015)
